MEDICAL SCIENCE
The Emergence, Spread, Possible Therapeutics, And Academic Impacts Of Ncovid-19 In India
by Dr. Prithiviraj Nagarajan
ISBN Number : 978 - 93 - 91478 - 03 - 2
Authors Details
Author Name | Image | About Author |
---|---|---|
Dr. Prithiviraj Nagarajan | Research Scientist , Multi-Disciplinary Centre for Biomedical Research,
Aarupadai Veedu Medical College & Hospital, Vinayaka Mission's
Research Foundation (Deemed to be University), Kirumampakkam,
Puducherry-607403, India. |
|
Dr. Anusheela Howlader | Assistant Professor, Department of Microbiology, Aarupadai Veedu
Medical College & Hospital, Vinayaka Mission's Research Foundation
(Deemed to be University), Kirumampakkam, Puducherry-607403,
India |
|
Dr. G. Subashchandrabose | Lecturer in Statistics, Community Medicine, Aarupadai Veedu Medical
College & Hospital, Vinayaka Mission's Research Foundation (Deemed
to be University), Kirumampakkam, Puducherry-607403, India |
|
Dr. Leena Rajathy Port Louis | Animal Welfare Ofcer, Department of Pharmacology Aarupadai Veedu
Medical College & Hospital, Vinayaka Mission's Research Foundation
(Deemed to be University), Kirumampakkam, Puducherry-607403,
India. |
Book Description
The beginning of 2021 has seen outbreaks of novel coronavirus COVID-19 infections, which have become a global pandemic. It is considered to have higher contagiousness and mortality compared to SARS and MERS. Clinical manifestations of nCOVID-19 symptoms are identied as coughs, fevers, vomiting, chills, joint pain, shortness of breath, and diarrhea. Older people over 70 years of age and those with chronic debilitating diseases such as end-stage illness, diabetes mellitus, hypertension, and pulmonary diseases are at a higher risk of mortality from nCOVID-19 infection. Currently, no specic approved antiviral drugs are available against nCOVID-19. Considering this imminent need, scientists and physicians have been racing to better understand this new pandemic virus-specic mechanism, pathophysiology, and target site of the disease to nd effective therapeutic agents and vaccines. This review summarized the origin, transmission, clinical symptoms, and conventional outcome treatment strategies of infection. It also included a discussion of the potential for recurrence. In our study, we emphasized reported potential repurposing drugs that are effective against SARS, MERS, and nCOVID-19, among other diseases. Our early knowledge will provide an overview of the intelligence basis work for currently existing therapeutic vaccines against nCOVID-19 that will be useful in the development of future vaccines. Preventive interventions and early diagnosis of nCOVID-19 outbreaks should be implemented immediately in order to reduce the disease burden both locally and worldwide.